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We performed a genome-wide association study (GWAS) and
a multistage meta-analysis of type 2 diabetes (T2D) in Punjabi
Sikhs from India. Our discovery GWAS in 1,616 individuals (842
case subjects) was followed by in silico replication of the top 513
independent single nucleotide polymorphisms (SNPs) (P , 1023)
in Punjabi Sikhs (n = 2,819; 801 case subjects). We further repli-
cated 66 SNPs (P , 1024) through genotyping in a Punjabi Sikh
sample (n = 2,894; 1,711 case subjects). On combined meta-
analysis in Sikh populations (n = 7,329; 3,354 case subjects),
we identified a novel locus in association with T2D at 13q12
represented by a directly genotyped intronic SNP (rs9552911,
P = 1.82 3 1028) in the SGCG gene. Next, we undertook in silico
replication (stage 2b) of the top 513 signals (P , 1023) in 29,157
non-Sikh South Asians (10,971 case subjects) and de novo geno-
typing of up to 31 top signals (P , 1024) in 10,817 South Asians
(5,157 case subjects) (stage 3b). In combined South Asian meta-
analysis, we observed six suggestive associations (P , 1025 to ,
1027), including SNPs at HMG1L1/CTCFL, PLXNA4, SCAP, and
chr5p11. Further evaluation of 31 top SNPs in 33,707 East Asians
(16,746 case subjects) (stage 3c) and 47,117 Europeans (8,130 case
subjects) (stage 3d), and joint meta-analysis of 128,127 individuals
(44,358 case subjects) from 27 multiethnic studies, did not reveal
any additional loci nor was there any evidence of replication for the
new variant. Our findings provide new evidence on the presence of a
population-specific signal in relation to T2D, which may provide addi-
tional insights into T2D pathogenesis.Diabetes 62:1746–1755, 2013
South Asians (people originating from the Indiansubcontinent) comprise more than a quarter ofthe global population and contribute the highestnumber of patients with type 2 diabetes (T2D) (1).
According to latest estimates, ;61 million people in India
alone are currently afflicted with T2D, and their number
is projected to increase to ;101 million by 2030 (2). Con-
sequently, ;60% of the world’s coronary artery disease
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(CAD), a principal cause of mortality in individuals with
T2D, is expected to occur in India (3). There is consider-
able ethnic difference in the prevalence and progression
of T2D and CAD. In addition to environmental factors,
genetic factors influence disease susceptibility (4). The
incidence of T2D and CAD is about three to five times
higher in immigrant South Asians compared with Euro-
Caucasians, and the age of onset of T2D is roughly a
decade earlier in South Asians than in Europeans (5–7).
The higher prevalence of T2D among South Asians settled
in developed countries compared with the host popula-
tion reflects the genetic and ethnic predisposition to
cardiometabolic disease under an adverse environment
and the joint effects of genes and environment in the
predisposition to T2D (8). For these reasons, we con-
ducted ethnic-specific genetic studies in a Sikh population
to dissect genetic pathways that may contribute to T2D
etiology in different ethnic groups.
The vast majority of genome-wide association studies
(GWAS) on T2D so far have been performed on Europeans.
Studies on non-European populations, especially those with
unique demographic and cultural histories, are important
for identifying population-specific linkage disequilibrium
(LD) patterns and environmental factors that may modulate
disease risk or protection (9). Interestingly, many, but not
all, of the common loci originally identified in Europeans
have been replicated in non-European groups (10–18). Re-
cent GWAS in non-European populations have yielded in-
triguing new variants (19–21), including six novel signals
in South Asians represented by single nucleotide poly-
morphisms (SNPs) near GRB14, ST6GAL1, VPS26A,
HMG20A, AP3S2, and HNF4A in our recent meta-analysis of
GWAS (22). Given the existence of marked genetic vari-
ability among South Asian communities, in addition to
diversity in culture, language, caste system, physical ap-
pearance, and diet, they do not constitute a single homoge-
neous community (23). Therefore, screening populations
with a different genetic and racial background or environ-
mental exposures may improve insights about the disease
and genetic risk factors (24).
People from India have a complex racial history com-
plicated by the presence of a caste system that has pro-
hibited interbreeding to a great extent and consequently
separated people into numerous endogamous groups (25).
The Sikhs, a relatively young, inbred population of ;26
million (2% of the Indian population), are from the north-
western province of India and follow a distinct and unique
religion born ;500 years ago in Punjab. They have an in-
teresting background for “nontraditional” disease enrich-
ment in the absence of conventional risk factors such as
smoking, obesity, and a diet rich in meats (26). Sikhs do
not smoke or chew tobacco because of religious and cul-
tural compulsions, and ;50% of them are lifelong vegeta-
rians. Despite the absence of these lifestyle-related risk
factors, T2D and CAD have reached epidemic proportions
in Sikhs. Our initial genetic studies in a Sikh cohort as part
of the Asian Indian Diabetic Heart Study (AIDHS) or the
Sikh Diabetes Study (SDS) revealed an association of FTO
and MTNR1B, ADIPOQ, and PPARG polymorphisms with
T2D and risk factors in the absence of obesity (11,27,28).
In this investigation, we conducted a GWAS in a relatively
homogenous Punjabi Sikh population of 1,850 individuals
and performed multistage replication in up to 27 case-
control studies of Punjabi, other South Asian, East Asian,
and Caucasian ancestries (total n = 128,127; 44,358 T2D
case and 83,769 control subjects) (Supplementary Tables
1 and 2). Study design of the discovery, replication, and
meta-analysis phases was optimized to detect new population-
specific and multiethnic T2D loci (Fig. 1). One important
difference in the current study from our previous South
Asian GWAS (22) is that in the previous study, the SNPs
that were common between South Asians and Europeans
were selected for replication based on the European Di-
abetes Genetics Replication and Meta-analysis (DIAGRAM)
sample. However, in this study, the SNP selection was
prioritized based on the top signals (P , 1023) from our
discovery Sikh cohort.
RESEARCH DESIGN AND METHODS
Participants. Participants were part of the Punjabi Sikh GWAS.
Study sample and characteristics. Our primary Sikh GWAS (discovery)
cohort used in this investigation is comprised of 1,616 individuals from the
Punjabi Sikh population that was a part of the AIDHS (also named the SDS). The
AIDHS/SDS has unique characteristics that are ideal for genetic studies. Sikhs
are strictly a nonsmoking population, and ;50% of participants are teetotalers
and life-long vegetarians. All individuals for the GWAS discovery cohort were
recruited from one geographical location. Diagnosis of T2D was confirmed by
scrutinizing medical records for symptoms and use of medication and mea-
suring fasting glucose levels according to the guidelines of the American Di-
abetes Association (29), as described previously (11). Data on lipids, insulin,
glucose, anthropometric measurements, education, socioeconomic status, job
grade, diet, and physical activity were available on .95% of the AIDHS/SDS
individuals selected for this study. Dietary questions involving alcohol con-
sumption were scored using a scale from 0 to 5; details are described else-
where (26). T2D is often asymptomatic and remains undiagnosed for many
years, especially in people from the developing world due to poor healthcare
provisions. Therefore, it is reasonable to assume that the actual age of onset of
T2D in Sikhs may range from 39 to 42 years of age compared with the ob-
served age at diagnosis (46 years). This age is in sharp contrast to the mean
age at onset of 60 years or above in developed countries (5,26,30). A medical
record indicating either 1) a fasting plasma glucose level $7.0 mmol/L ($126
mg/dL) after a minimum 12-h fast or 2) a 2-h postglucose level of $11.1 mmol/L
($200 mg/dL) estimated during a 2-h oral glucose tolerance test on more
than one occasion, combined with symptoms of diabetes, confirmed the di-
agnosis. Impaired fasting glucose is defined as a fasting blood glucose level
$5.6 mmol/L ($100 mg/dL) but #7.0 mmol/L (#126 mg/dL). Impaired glucose
tolerance is defined as a 2-h OGTT.7.8 mmol/L (.140 mg/dL) but,11.1 mmol/L
(,200 mg/dL). The 2-h OGTTs were performed according to the criteria of the
World Health Organization (75-g oral load of glucose). BMI was calculated as
weight (kg)/height (m)2, and waist-to-hip ratio was calculated as the ratio of
abdomen or waist circumference to hip circumference. Subjects with type 1
diabetes, or those with a family member with type 1 diabetes, or rare forms of
T2D subtypes (maturity-onset diabetes of the young) or secondary diabetes
(from, e.g., hemochromatosis or pancreatitis) were excluded from the study.
The selection of control subjects was based on a fasting glucose ,100.8 mg/dL
or a 2-h glucose ,141.0 mg/dL. Subjects with impaired fasting glucose or im-
paired glucose tolerance were excluded when data were analyzed for associa-
tion of the variants with T2D. All blood samples were obtained at the baseline
visits. All participants signed a written informed consent for the investigations.
The study was reviewed and approved by the University of Oklahoma Health
Sciences Center Institutional Review Board, as well as the Human Subject
Protection Committee at the participating hospitals and institutes in India.
South Asian cohorts. For stage 2a replication, the Sikh component of the
London Life Sciences Population (LOLIPOP) study (22) comprised 2,919 indi-
viduals (801 T2D case and 2,018 control subjects). For stage 2b, the non-Sikh
South Asian components of the LOLIPOP and the Pakistan Risk of Myocardial
Infarction Study (PROMIS; and the Risk Assessment of Cerebrovascular Events
[RACE] study) GWAS (22) comprised 29,157 individuals (10,971 case and 18,186
control subjects) (22). Stage 3a Punjabi-specific replication was carried out on
2,894 individuals (1,711 case and 1,183 control subjects) of Punjabi ancestry
from India as part of AIDHS/SDS, and replication testing among South Asians for
stage 3b was carried out among 10,817 participants (5,157 case and 5,660 control
subjects), which were part of the following studies: Asian Indians from the
Singapore Indian Eye (SINDI) study (31), the Chennai Urban Rural Epidemiol-
ogy Study (CURES) (32), the Diabetes Genetics in Pakistan (DGP) study, the
UK Asian Diabetes Study (UKADS) (33), and the Sri Lankan Diabetes Study
(SLDS) (34). Details of the contributing cohorts are provided in the Supplementary
Data.
East Asian cohorts. Replication testing for stage 3c was carried out on a total
of 33,707 East Asians, comprising 14,890 Japanese from RIKEN (n = 7,480
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genotyped) and BioBank Japan (n = 7,410 GWAS) (19,35) and 18,817 indi-
viduals of East Asian ancestry as part of the Asian Genetic Epidemiology
Network (AGEN) with genotype data available from eight GWAS (21).
DIAGRAM (Euro-Caucasians). Associations of SNPs with T2D among
Europeans were tested in silico using results from the genome-wide association
phase of the DIAGRAM study comprising 47,117 subjects (36).
Genotyping and quality control. Genomic DNA was extracted from buffy
coats using QiaAmp blood kits (Qiagen, Chatsworth, CA) or by the salting-out
procedure (37). Stage 1 genome-wide genotyping was performed using a Hu-
man 660W-Quad BeadChip panel (Illumina, Inc., San Diego, CA). We per-
formed pairwise identity-by-state clustering in PLINK across all individuals to
assess population stratification; no population outliers were detected. Related
individuals with pi-hat .0.3 and samples with ,93% call rate were excluded,
as were SNPs with call rate ,95%. Also excluded were SNPs with Hardy-
Weinberg equilibrium (HWE) P , 1026 or minor allele frequency (MAF) ,1%.
After quality control, 524,216 directly genotyped SNPs in 1,616 subjects (842
case and 774 control subjects) were available for association testing.
Genotyping for de novo SNPs in the replication samples was performed by
SequenomMassArray (BioMark HDMX/HXGenetic Analysis System; Fluidigm)
or KASPAR (LGC Genomics KBioscience, London, U.K.). Samples and SNPs
with ,95% call rate were excluded, as were those that deviated from HWE at
P , 1023. The associations of SNPs with T2D were tested in each cohort
separately.
Statistical analyses
Association testing.Associations of SNPs with T2Dwere tested using logistic
regression and an additive genetic model. Age, sex, BMI, and 5 or 10 principal
components to adjust for residual population stratification were included as
covariates. As the existing HapMap2 or HapMap3 and 1000 Genomes data do
not include Sikhs, the 5 or 10 principal components used for this correction
were estimated using our Sikh population sample and not the HapMap pop-
ulations. After association analyses, the genomic control inflation factor (l)
was 1.0, so no adjustments were made (Supplementary Fig. 2A and B).
In addition to the analysis of directly genotyped SNPs, we performed im-
putation using the Impute 2 program (38–40), which determines the probability
distribution of missing genotypes based on a set of known haplotypes and an
estimated fine-scale recombination map. Imputation was based on the entire
multiethnic HapMap3 reference panel of ;1.5 million autosomal SNPs with
MAF .1% in 1,011 individuals from Africa, Asia, Europe, and the Americas
(including 1,362,138 SNPs from the Indian population of 100 Gujaratis from
Houston [GIH]). Imputation yielded a total of 1,232,008 passing SNPs with
MAF .1% in the Sikh GWAS. Imputed SNPs were analyzed using SNPTEST
(38,40), adjusted for the covariates age, sex, BMI, and five principal compo-
nents, which implements frequentist tests that calculate P values and param-
eter estimates and their standard errors that account for the uncertainty due to
the probability distributions of the imputed genotypes, and included only
those SNPs with an information score $0.5 in the discovery sample as well as
in all GWAS used for replication, a measure of the relative statistical in-
formation about the additive genetic effect being estimated. The genomic
control value for imputed SNPs was 1.02. The inbreeding coefficient and
measures of autozygosity were determined using the program PLINK. We
identified runs of homozygosity using the metrics defined in Nalls et al. (41),
evaluating 1-Mb autosomal regions with at least 50 adjacent SNPs, with
a sliding window of 50 SNPs including no more than 2 SNPs with missing
genotypes and one possible heterozygous genotype.
Stage 2 replication. We selected all independent association signals
(r2 ,0.25) with P , 1023 for lookup in GWAS of 1) the Sikh component of the
LOLIPOP GWAS (22) and 2) the non-Sikh South Asian components of the
LOLIPOP and PROMIS GWAS (22). A fixed-effect, inverse-variance meta-
analysis (as implemented in METAL) (42) was used to combine the results for
individual studies.
Stage 3 replication. Significant association results with P , 1023 based on
meta-analysis of stages 1, 2a, and 2b were selected for de novo or in silico
replication in Sikh, South Asian, other Asian, and European populations. In
addition, we selected SNPs from a Sikh-only meta-analysis of stages 1a and 2a
for genotyping in an in-house Punjabi Sikh T2D case-control population. In our
previous South Asian GWAS by Kooner et al. (22), 300 of the 3,200 samples of
the AIDHS/SDS (used in replication) were genotyped using Illumina 660 Quad
arrays, and the remaining samples (from 1,187 case and 1,632 control sub-
jects) were genotyped using Sequenom MassARRAYs. However, in this study,
in addition to GWAS set (n = 1,616), SNPs were genotyped de novo on our
remaining replication set (n = 2,894). Signals with P, 1024 after meta-analysis
of stages 1, 2a, and 3a were also genotyped in the South Asian, other Asian,
and European populations to test if they were specific to the Sikh ethnic group
or spanned ethnicities. All meta-analyses were performed using a fixed-effects,
inverse-variance meta-analysis implemented in METAL.
MuTHER Consortium. The Multiple Tissue Human Expression Resource
(MuTHER; www.muther.ac.uk) includes lymphoblastic cell lines and skin and
adipose tissue derived simultaneously from a subset of well-phenotyped
FIG. 1. Summary of study design and outcome of key findings.
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healthy female twins from the Twins UK adult registry. Whole-genome expres-
sion profiling of the samples, each with either two or three technical replicates,
was performed using the Illumina HumanHT-12 v3 BeadChips according to the
protocol supplied by the manufacturer. Log2-transformed expression signals
were normalized separately per tissue as follows. Quantile normalization was
performed across technical replicates of each individual followed by quantile
normalization across all individuals. Genotyping was performed with a combi-
nation of Illumina arrays HumanHap300, HumanHap610Q, 1M-Duo, and
1.2MDuo 1M. Untyped HapMap2 SNPs were imputed using the IMPUTE soft-
ware package (v2). The number of adipose samples with genotypes and ex-
pression values is 776. Association between all SNPs (MAF .5%; IMPUTE info
.0.8) within a gene or within 1 Mb of the gene transcription start or end site and
normalized expression values was performed with the GenABEL/ProbABEL
packages using the polygenic linear model incorporating a kinship matrix in
GenABEL followed by the ProbABEL mmscore score test with imputed geno-
types. Age and experimental batch were included as cofactors.
RESULTS
Punjabi Sikh discovery GWAS. Clinical characteristics
of the stage 1 Punjabi Sikh T2D GWAS cohort and stage 2a
and 2b (replication) cohorts are described in Supplemen-
tary Table 3. Principal components analysis revealed little
population structure (Supplementary Fig. 1). After quality
control, 524,216 directly genotyped SNPs in 1,616 subjects
(842 case and 774 control subjects) from 1,850 total sub-
jects were available for association testing after removing
samples showing cryptic relatedness through identity-
by-descent sharing. To increase genome coverage, geno-
types were imputed for untyped SNPs using the HapMap3
multiethnic reference panel (see RESEARCH DESIGN AND
METHODS), yielding a total of 1,232,008 SNPs for association
analyses. The reason for choosing a more cosmopolitan
panel and not restricting to the GIH was based on our own
data showing equal diversity of the Sikhs from GIH and
CEU, and based on previously described advantages of
using a worldwide reference panel (39). We performed
a GWAS for T2D adjusted for covariates age, sex, BMI, and
five principal components (Supplementary Fig. 1); no evi-
dence of inflation was observed (Supplementary Fig. 2A
and B) (see RESEARCH DESIGN AND METHODS).
Replication and meta-analyses in Punjabi Sikh
participants. We undertook a two-stage replication in
T2D case-control samples of Punjabi Sikh ancestry (stages
2a and 3a in Fig. 1). Lead SNPs representing 513 novel,
independent (r2,0.25) association signals with P, 1023 in
the discovery GWAS (including only two previously known
GWAS SNPs from TCF7L2 and IGF2BP2 and excluding 62
SNPs with P , 1023 from other known T2D loci) were
tested for in silico replication in the Punjabi Sikh sub-
component of the LOLIPOP GWAS comprising 801 T2D
case and 2,018 control subjects (Supplementary Table 1).
Top SNPs representing 66 putatively novel signals with
P , 1024 after stage 1 and 2a meta-analysis using a fixed
effects, inverse-variance approach were directly geno-
typed in the stage 3a sample of 2,894 Punjabi Sikh indi-
viduals (1,711 T2D case and 1,183 control subjects) (Fig. 1
and Supplementary Table 2).
In a combined meta-analysis of the three Punjabi studies
(n = 7,329), we identified one new locus reaching genome-
wide significance (P , 5 3 1028) along with robust repli-
cation of the established SNP rs7903146 in TCF7L2 (P =
3.32 3 10219) in Sikhs (Figs. 2, 3, and 4). This novel as-
sociation signal lies in a 164-kb region of strong LD at
13q12 (harboring genes gamma-sarcoglycan [SGCG] and
sacsin [SACS]) and is represented by a directly genotyped
intronic SNP, rs9552911 in SGCG (odds ratio [OR] 0.67
[95% CI 0.58–0.77], P = 1.823 1028 for the minor “A” allele)
(Table 1, Fig. 4, and Supplementary Table 5). Excluding
BMI from the logistic regression model did not affect the
association (Supplementary Table 6). Furthermore, in-
cluding five additional principal components in the model
did not attenuate the signal; indeed, the effect and signif-
icance were slightly improved (Supplementary Table 6).
The genetic variance (R2) explained by this variant for the
T2D phenotype in Punjabi Sikh discovery and replication
sets was 1.57 and 1.34%, respectively. There were 15 ad-
ditional independent loci with suggestive evidence (P ,
1025 to , 1027) of association, including six unknown
regions along with IGF2BP2, originally identified in Cau-
casians (43) (Supplementary Table 5). Meta-analysis
results including non-Sikh Punjabis from PROMIS (Paki-
stan) revealed suggestive association (P, 1025 to, 1027)
at SNPs from three new regions: chromosome 18q21
ZBTB7C (rs1893835), 20q13, near HMG1L1/CTCFL/
RBM38/PCK1 (rs328506), and 5q33 (rs17053082) (Supple-
mentary Table 7). Association results for 42 previously
reported T2D loci in the Punjabi cohort are summarized in
Supplementary Table 14. Most loci showed consistent ef-
fect in the same direction and 33 out of 42 were associated
with T2D at P , 0.05 in Sikhs.
Replication/evaluation and meta-analysis in other
South Asians. In order to identify T2D association sig-
nals common to Punjabi and other South Asian pop-
ulations, we tested the association of the 513 top
independent signals (P, 1023) derived from the discovery
cohort in GWAS from the LOLIPOP, PROMIS, and RACE
studies as part of stage 2b replication (10,971 T2D case and
18,186 control subjects) (Fig. 1 and Supplementary Table
1). Thirty-one signals (P , 1024 from an interim analysis
with stage 2b) were further genotyped in 10,817 South
Asians (5,157 T2D and 5,660 control subjects) (Fig. 1) as
part of stage 3b replication. Clinical characteristics of the
stage 3 replication cohorts are described in Supplementary
Table 4. Combined South Asian meta-analysis revealed
nominally significant association in six SNPs with MAF
.5% (P # 1024), but only the two previously known SNPs
in TCF7L2 and IGF2BP2 reached genome-wide signifi-
cance (Table 1 and Supplementary Table 8). Suggestive
novel signals included SNPs at chromosome 20q13, near
HMG1L1/CTCFL/RBM38/PCK1 (rs328506), 7q32 near
PLXNA4 (rs1593304), 3p21 in SCAP (rs4858889), and 5p11
(rs13155082) (Supplementary Table 8). Further studies
and replication in a larger sample will be required to val-
idate these results and identify causal variants at these
loci.
Multiethnic replication and meta-analysis. To identify
T2D signals spanning ethnicities, we extended the replica-
tion of 31 SNPs with P , 1024 in Punjabis and South Asians
(stage 3b) to East Asians (AGEN+) and Europeans (DIA-
GRAM+) in stages 3c and 3d, respectively (Fig. 1). Upon
meta-analysis of 31 loci in Asians (South Asians and AGEN
+), genome-wide associations were only seen in TCF7L2
(rs7903146, P = 1.93 3 10238) and IGF2BP2 (rs1470579, P =
1.54 3 10213) (Supplementary Table 9). In joint multiethnic
meta-analysis on 128,127 individuals from 27 studies, only
two previously known loci, TCF7L2 (rs7903146, P = 8.53 3
10275) and IGF2BP2 (rs1470579, P = 1.81 3 10219), showed
robust associations. Interestingly, none of the Punjabi hits
could be independently confirmed in AGEN+ or DIAGRAM+
(notably, the lead rs9552911 variant from SGCG was
monomorphic in DIAGRAM+) (Table 1 and Supplementary
Table 10). Lookup of 50 kb upstream and downstream of
SNPs within the SGCG locus in the publicly available data of
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the Meta-Analyses of Glucose and Insulin-Related Traits
Consortium (MAGIC) study on glycemic trait GWAS (44,45)
revealed several nominal associations of SNPs with fasting
blood glucose and 2-h glucose levels (Supplementary Fig. 3).
Some of these SNPs also showed an association with fasting
blood glucose and waist or waist-to-hip ratio in Sikhs
(Supplementary Table 11), but none of these were in LD
(r2 .0.20) with our lead SNP.
Gene expression studies. We examined the expression
of SGCG and neighboring genes (FLJ46358, MIPEP,
SACS, and sTNFRSF19) within 1 Mb of the index SNP by
cis expression quantitative trait locus (eQTL) analysis us-
ing adipose tissue, skin, and lymphoblastic cell line gene
expression data from the MuTHER Consortium, compris-
ing healthy female twins of European ancestry from Brit-
ain. Several SNPs in the SGCG region were associated with
FIG. 2. A: Manhattan plot showing primary genome-wide association analysis of the Punjabi Sikh discovery cohort using directly genotyped
(524,216) SNPs. B: Manhattan plot shows imputed 1,232,008 SNPs on the x-axis and 2log10 P value of association on the y-axis. Locations of the
three loci (including one novel locus at SGCG) reached genome-wide significance after combined analysis of the GWAS and replication data in
Punjabi Sikhs.
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significantly elevated (PeQTL , 10
24 to , 1029) expression
of SGCG mRNA in adipose tissues (Supplementary Table
12 and Supplementary Fig. 4). One adipose eQTL from
MuTHER (rs572303, PeQTL = 5.47 3 10
24) located within
SGCG showed a nominally significant association with
increased waist circumference in Sikhs (b = 0.67, P = 5.23
1022) (Supplementary Table 11). As shown in Supple-
mentary Fig. 4, the LD patterns in the region (;1.46 Mb)
surrounding the SGCG variant (rs9552911) varied in East
Asians (JPT), Africans (YRI), Caucasians (CEU), Gujarati
Indians (GIH), and Sikhs. Interestingly, in Caucasians
and Yorubians, this variant was monomorphic. However,
several alternative SNPs from this region in Europeans
were nominally associated with fasting blood glucose
(MAGIC study, r2 ranging from 0.10 to 0.20 with the index
SNP [rs9552911]) and mRNA expression of adipose cells in
FIG. 3. A: Regional association plot for a new T2D locus detected at 13q12 in the SGCG gene from the genome-wide meta-analysis in Sikhs. B: A
strong confirmation of SNPs in the TCF7L2 gene in Sikh meta-analysis. In these plots, the SNPs showing the most strongly associated signal are
depicted as a red diamond with blue border for the combined stage 1, 2a, and 3a results for meta-analysis, and the red diamond with black border
shows evidence of association for the stage 1 results. Each square in color shows a SNP with the color scale relating the r2 value for that SNP and
the top SNP taken from the HapMap 3 GIH panel. We present LD using the GIH panel, the closest HapMap population to the Sikhs; however, we
note that there could still be differential LD between the reference panel and the Sikh population. At the bottom of the plot, the locations of known
genes in the region are shown.
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the MuTHER study (r2 ranging from 0.14 to 0.26 with the
index SNP). These data suggest that population differ-
ences may underlie the weak LD. It is possible that a single
causal variant may be responsible for these associations,
but LD may differ between Sikhs, Europeans, and other
populations.
Comparative analysis of autozygosity. We further
looked to compare the distributions of inbreeding coef-
ficients and autozygosity as described by Nalls et al. (41).
As expected, the inbreeding coefficients in our sample
were higher compared with two outbred populations of
European Americans, Coriell, and Baltimore Longitudinal
Study of Aging (BLSA) (F = 0.041 6 0.018 in Sikhs vs. F =
0.007 6 0.019 in Coriell and F = 20.3 6 0.012 in BLSA), as
assessed by Nalls et al. (41). However, these results were
similar to other Indian populations previously reported by
Reich et al. (46). No significant difference in inbreeding
was observed between case and control subjects (P =
0.59). Autozygosity analysis determined that there were
19 6 7 homozygous segments .1 Mb in length, with an
average length of 2.0 6 0.95 Mb. Hence, fewer but longer
autozygous segments were found in our population than in
outbred populations. No correlation of measures of
autozygosity to age was observed (P . 0.05) across dec-
ades of age.
DISCUSSION
In this GWAS and multistage meta-analysis, a novel locus
at 13q12 in the SGCG gene (rs9552911, P = 1.82 3 1028)
was identified as associated with T2D susceptibility in
Punjabi Sikhs from Northern India.
SGCG is a member of the sarcoglycan complex of
transmembrane glycoproteins mutated in autosomal re-
cessive muscular dystrophy, in particular limb-girdle mus-
cular dystrophy type 2C (LGMD2C). SGCG is expressed in
skeletal muscle, and its high expression is also seen in
vascular smooth muscle cells as well as in breast cancer cell
lines (47,48). Founder mutations in SGCG that cause
LGMD2C predate migration of the Romani gypsies of
Europe out of India around 1100 AD (49). Due to complete
endogamy, this genetically isolated community had an in-
creased incidence of autosomal recessive LGMD2C. SGCG-
targeted knockout mice displayed a variety of phenotypes,
including dystrophic cardiomyopathy and defects in skele-
tal muscle, metabolism, homeostasis, growth, apoptosis,
aging, and behavior (50–53). Mice lacking the sarcoglycan
FIG. 4. Forest plot showing the association of lead SNP in the SGCG (rs9552911) gene with T2D. For each study, the estimates of the ORs with 95%
CI are shown. In addition, meta-analyses of Sikhs and South Asians and multiethnic studies are shown at the bottom. Meta-analysis in Sikhs shows
a significant association of rs9552911 with T2D (OR 0.67 [0.58–0.77], P = 1.82 3 1028). The red diamond signifies the OR and CI across all mul-
tiethnic samples.
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complex including SGCG in adipose and skeletal muscle
were shown to be glucose intolerant and exhibited whole-
body insulin resistance due to impaired insulin-stimulated
glucose uptake in skeletal muscle (54).
The allelic distribution of the less common “A” (pro-
tective) allele of rs9552911 ranged from 0.06 to 0.15 in South
Asians and differed between other South Asians (0.11) and
Punjabi Sikhs (0.08) (see details in Supplementary Table
13). Further replication in large independent datasets of
South Asians and Punjabi Sikhs would be needed to confirm
the pattern of observed association. In view of the complex
racial history complicated by a well-defined caste system,
Indian populations display a great deal of genetic and cul-
tural diversity (55). Studies suggest that genetic affinity
among endogamous communities in India is inversely cor-
related with geographic distance between them (23).
Therefore, it is possible that undetected causal variant(s) or
multiple rare variants in LD with this marker arose on a hap-
lotype tagged by rs9552911 in Punjabi Sikhs after divergence
from other South and West Indian populations. This variation
in the index SNP rs9552911 does not appear to be of re-
cent origin, as suggested by comparative genomic analysis
(Supplementary Fig. 5). Two important nuclear hormone
receptors and transcription factors (peroxisome proliferator–
activated receptor-g [PPAR-g] [1 and 2] and PPAR-a) bind to
the promoter and intron 1 of the SGCG gene. Further, the
maturity-onset diabetes of young 4 (MODY4) locus at chro-
mosome 13q12, represented by insulin promoter factor 1 or
PDX-1, lies next to the SGCG locus. Therefore, further in-
depth examination by targeted resequencing in the extended
region and functional studies may reveal putative causative
variants in this extended region and provide insight into the
physiological relevance of the observed association.
In summary, our study identified a novel locus associated
with T2D in a population of Punjabi Sikh ancestry from
Northern India. These findings not only provide new in-
formation on previously unknown regions associated with
T2D but demonstrate a putative population-specific associ-
ation that could lead to additional biological insights into
T2D pathogenesis.
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